These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19188376)

  • 1. Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
    Mulet X; Maciá MD; Mena A; Juan C; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1552-60. PubMed ID: 19188376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Time Monitoring of
    Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms.
    Gillis RJ; White KG; Choi KH; Wagner VE; Schweizer HP; Iglewski BH
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3858-67. PubMed ID: 16127063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y; Huang J; Li L; Liu L
    Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
    Jeannot K; Elsen S; Köhler T; Attree I; van Delden C; Plésiat P
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2455-62. PubMed ID: 18474583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
    Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
    J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.
    Rojo-Molinero E; Macià MD; Rubio R; Moyà B; Cabot G; López-Causapé C; Pérez JL; Cantón R; Oliver A
    Antimicrob Agents Chemother; 2016 May; 60(5):2912-22. PubMed ID: 26926631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
    Hoffmann N; Lee B; Hentzer M; Rasmussen TB; Song Z; Johansen HK; Givskov M; Høiby N
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3677-87. PubMed ID: 17620382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa.
    Poole K; Gotoh N; Tsujimoto H; Zhao Q; Wada A; Yamasaki T; Neshat S; Yamagishi J; Li XZ; Nishino T
    Mol Microbiol; 1996 Aug; 21(4):713-24. PubMed ID: 8878035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.
    Ahmed MN; Porse A; Abdelsamad A; Sommer M; Høiby N; Ciofu O
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa.
    Stickland HG; Davenport PW; Lilley KS; Griffin JL; Welch M
    J Proteome Res; 2010 Jun; 9(6):2957-67. PubMed ID: 20373734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.
    Macià MD; Pérez JL; Molin S; Oliver A
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5230-7. PubMed ID: 21859941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.
    Maciá MD; Borrell N; Segura M; Gómez C; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):975-83. PubMed ID: 16495260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin retards Pseudomonas aeruginosa biofilm formation.
    Gillis RJ; Iglewski BH
    J Clin Microbiol; 2004 Dec; 42(12):5842-5. PubMed ID: 15583321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators.
    Morero NR; Monti MR; Argaraña CE
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3668-76. PubMed ID: 21646492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative mapping of mRNA 3' ends in Pseudomonas aeruginosa reveals a pervasive role for premature 3' end formation in response to azithromycin.
    Konikkat S; Scribner MR; Eutsey R; Hiller NL; Cooper VS; McManus J
    PLoS Genet; 2021 Jul; 17(7):e1009634. PubMed ID: 34252072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Combined Ciprofloxacin and azithromycin free and nano formulations to control biofilm producing Pseudomonas aeruginosa isolated from burn wounds.
    Raouf M; Essa S; El Achy S; Essawy M; Rafik S; Baddour M
    Indian J Med Microbiol; 2021 Jan; 39(1):81-87. PubMed ID: 33460732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa.
    Purssell A; Poole K
    Microbiology (Reading); 2013 Oct; 159(Pt 10):2058-2073. PubMed ID: 23924707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-coated pH-responsive dimeric prodrug-based nano-assemblies with high biofilm eradication capacity.
    Li X; Li W; Li K; Chen X; Wang C; Qiao M; Hong W
    Biomater Sci; 2023 Jan; 11(3):1031-1041. PubMed ID: 36545821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.